Biotech is a dynamic industry that is driving scientific advancements and innovation in healthcare.
In Canada, the biotech industry is home to companies pursuing cutting-edge therapies and medical technologies, and the Investing News Network has identified the top three biotech stocks based on their year-on-year gains.
Year-on-year gain: 7,900 percent; market cap: C$93.45 million; share price: C$4.00
Year-on-year gain: 172.86 percent; market cap: C$153.89 million; share price: C$1.91
Medicenna is a clinical-stage immuno-oncology company specializing in the development of innovative therapies for patients with challenging unmet needs. Its focus is on creating novel, highly selective versions of cytokines, such as IL-2, IL-4, and IL-13, which it refers to as “Superkines” and “empowered superkines.”
Year-on-year gain: 116 percent; market cap: C$188.37 million; share price: C$2.70
Cardiol Therapeutics is a biopharma company developing innovative treatments for inflammation and fibrosis in cardiovascular conditions. Its research is concentrated on pericarditis, which is inflammation of the membrane surrounding the heart; myocarditis, or inflammation of the heart muscle; and heart failure.
Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Cardiol Therapeutics is a client of the Investing News Network. This article is not paid-for content.
Leave a Reply